Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12134642
Antibodies binding to α7β1 integrin antibodies and compositions thereof
granted -
US 12134631
Hydrophilic linkers for antibody drug conjugates
granted -
US 12133840
Halogenated xanthene composition and method for treating hematologic cancers
granted -
US 12133856
Multi-substituent psilocybin derivatives and methods of using
granted -
US 12133924
Compositions and methods for organ specific delivery of nucleic acids
granted -
US 12133853
Pyruvate kinase activators for use in treating blood disorders
granted -
US 12133849
Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha- emitting radioimmunotherapeutic
granted -
US 12134610
Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof
granted -
US 12133914
Hydrocortisone oral liquid formulations
granted -
US 12133884
Methods of substituting pathogenic amino acids using programmable base editor systems
granted -
US 12134609
Quinoline cGAS antagonist compounds
granted -
WO 2024223388
COMPLEXES CRISTALLINS ENTRE LA VELAGLIFLOZINE ET DES AGENTS DE FORMATION DE CO-CRISTAUX SÉLECTIONNÉS, LEURS PROCÉDÉS DE PRÉPARATION ET LEUR UTILISATION POUR LA PRÉPARATION DE MÉDICAMENTS
granted -
US 12127536
Humanized M-CSF mice
granted -
US 12128015
APE/REF1 inhibitors for the treatment of cancer
granted -
US 12128013
Toxic aldehyde related diseases and treatment
granted -
US 12128048
Combination therapies using PRMT5 inhibitors for the treatment of cancer
granted -
US 12128044
Fused tricyclic compounds and uses thereof in medicine
granted -
US 12128034
Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof
granted -
US 12128058
Multi-substituent psilocybin derivatives and methods of using
granted -
US 12128090
Methods of prophylactic treatment using recombinant VWF (rVWF)
granted -
US 12128033
Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine
granted -
US 12128052
Pharmaceutical compositions comprising meloxicam
granted -
US 12129222
Production of bitter principle derivatives
granted -
US 12128122
Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.